12:10 PM EST - Response Biomedical Corp. : said its third-quarter net loss narrowed to $3.17 million or $0.01 per share from $3.68 million or $0.03 in the prior-year period. Total revenues for the quarter increased to $2.04 million from $1.47 million in the comparable period. Net loss for the nine months ended September 30, 3009, also narrowed to $6.80 million or $0.03 per share from $10.96 million or $0.08 in the year-ago period. Total revenues for the period rose to $7.49 million from $3.64 million in the previous year. Response Biomedical Corp.
shares T.RBM are trading down $0.01 at $0.14.
